Rennova Health (RNVA)
(Delayed Data from OTC)
$0.00 USD
0.00 (0.00%)
Updated Sep 19, 2024 12:12 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Rennova Health, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 1 | 1 | 0 | 0 |
Receivables | NA | 5 | 4 | 2 | 4 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 1 |
Other Current Assets | NA | 0 | 0 | 0 | 1 |
Total Current Assets | NA | 6 | 5 | 3 | 5 |
Net Property & Equipment | NA | 4 | 5 | 8 | 8 |
Investments & Advances | NA | 9 | 9 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 1 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 21 | 20 | 12 | 15 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | NA | 6 | 7 | 7 | 19 |
Accounts Payable | NA | 12 | 12 | 14 | 14 |
Current Portion Long-Term Debt | NA | 9 | 8 | 13 | 30 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 1 |
Accrued Expenses | NA | 20 | 16 | 19 | 15 |
Income Taxes Payable | NA | 1 | 1 | 1 | 1 |
Other Current Liabilities | NA | 2 | 2 | 4 | 4 |
Total Current Liabilities | NA | 49 | 46 | 59 | 83 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 1 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 8 |
Total Liabilities | NA | 50 | 47 | 61 | 91 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 3 | 0 | 0 | 1 |
Capital Surplus | NA | 1,672 | 1,342 | 819 | 509 |
Retained Earnings | NA | -1,704 | -1,369 | -869 | -587 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | -29 | -27 | -49 | -77 |
Total Liabilities & Shareholder's Equity | NA | 21 | 20 | 12 | 15 |
Total Common Equity | 0 | -29 | -27 | -49 | -77 |
Shares Outstanding | 40,551.30 | 29,084.30 | 44,276.50 | 0.00 | 0.00 |
Book Value Per Share | 0.00 | 0.00 | 0.00 | -49.04 | -76.54 |
Fiscal Year End for Rennova Health, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,999 | -99,999 | 0 | 1 |
Receivables | NA | NA | NA | 5 | 6 |
Notes Receivable | NA | NA | NA | 0 | 0 |
Inventories | NA | NA | NA | 0 | 0 |
Other Current Assets | NA | NA | NA | 0 | 0 |
Total Current Assets | NA | NA | NA | 6 | 7 |
Net Property & Equipment | NA | NA | NA | 4 | 4 |
Investments & Advances | NA | NA | NA | 9 | 9 |
Other Non-Current Assets | NA | NA | NA | 0 | 0 |
Deferred Charges | NA | NA | NA | 0 | 0 |
Intangibles | NA | NA | NA | 0 | 0 |
Deposits & Other Assets | NA | NA | NA | 0 | 0 |
Total Assets | NA | NA | NA | 20 | 22 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | NA | 3 | 4 |
Accounts Payable | NA | NA | NA | 12 | 13 |
Current Portion Long-Term Debt | NA | NA | NA | 8 | 8 |
Current Portion Capital Leases | NA | NA | NA | 0 | 0 |
Accrued Expenses | NA | NA | NA | 19 | 19 |
Income Taxes Payable | NA | NA | NA | 2 | 2 |
Other Current Liabilities | NA | NA | NA | 2 | 2 |
Total Current Liabilities | NA | NA | NA | 47 | 48 |
Mortgages | NA | NA | NA | 0 | 0 |
Deferred Taxes/Income | NA | NA | NA | 0 | 0 |
Convertible Debt | NA | NA | NA | 0 | 0 |
Long-Term Debt | NA | NA | NA | 0 | 0 |
Non-Current Capital Leases | NA | NA | NA | 0 | 0 |
Other Non-Current Liabilities | NA | NA | 0 | 0 | |
Minority Interest (Liabilities) | NA | NA | NA | 0 | 0 |
Total Liabilities | NA | NA | NA | 47 | 49 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | NA | 0 | 0 |
Common Stock (Par) | NA | NA | NA | 4 | 3 |
Capital Surplus | NA | NA | NA | 1,671 | 1,671 |
Retained Earnings | NA | NA | NA | -1,702 | -1,701 |
Other Equity | NA | NA | NA | 0 | 0 |
Treasury Stock | NA | NA | NA | 0 | 0 |
Total Shareholder's Equity | NA | NA | NA | -28 | -27 |
Total Liabilities & Shareholder's Equity | NA | NA | NA | 20 | 22 |
Total Common Equity | 0 | 0 | 0 | -28 | -27 |
Shares Outstanding | 40,551.30 | 40,551.30 | 40,551.30 | 37,051.30 | 29,934.30 |
Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |